January 08, 2019 article Open access Tumor mutational load predicts survival after immunotherapy across multiple cancer types Nature Genetics DOI: 10.1038/s41588-018-0312-8 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 28 stored of 4,465 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy 2026 European Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers 4 citations Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol 2025 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 2 citations Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications 2024 JTO Clinical and Research Reports article Medicine Lung Cancer Diagnosis and Treatment Open access 3 citations Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma 2024 Scientific Reports article Medicine Cancer Immunotherapy and Biomarkers Open access 16 citations Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol 2024 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 4 citations Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer 2024 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 34 citations Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma 2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers 23 citations Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications 2023 Cancers article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access 28 citations Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours 2023 BMC Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 13 citations Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment 2023 The Journal of Clinical Endocrinology & Metabolism article Medicine Pituitary Gland Disorders and Treatments Open access 86 citations CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden 2023 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 29 citations Mechanisms driving the immunoregulatory function of cancer cells 2023 Nature reviews. Cancer review Medicine Cancer Immunotherapy and Biomarkers 272 citations The immune landscape of solid pediatric tumors 2022 Journal of Experimental & Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 39 citations Beyond the snapshot: optimizing prognostication and prediction by moving from fixed to functional multidimensional cancer pathology 2022 The Journal of Pathology article Computer Science AI in cancer detection Open access 4 citations First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 2022 Annals of Oncology article Medicine Occupational and environmental lung diseases Open access 266 citations Immunogenomic, single-cell and spatial dissection of CD8 + T cell exhaustion reveals critical determinants of cancer immunotherapy 2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 7 citations Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme 2021 Cancer Research article Medicine Glioma Diagnosis and Treatment Open access 31 citations Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger? 2021 Biomedicines article Medicine Cancer Immunotherapy and Biomarkers Open access 10 citations Regulation of PD1 signaling is associated with prognosis in glioblastoma multiforme 2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Glioma Diagnosis and Treatment Open access 4 citations Germline genetic contribution to the immune landscape of cancer 2021 Immunity article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 182 citations 1–20 of 28 Page 1 / 2 Next → References 0